24 weeks of interferon-ribavirin therapy should not routinely be given to all hepatitis C patients.
作者信息
van Leeuwen D J, Yee Leland J, Langner Rebecca G
出版信息
Am J Gastroenterol. 2002 Feb;97(2):497-8. doi: 10.1111/j.1572-0241.2002.05512.x.
Abstract
摘要
相似文献
1
24 weeks of interferon-ribavirin therapy should not routinely be given to all hepatitis C patients.
Am J Gastroenterol. 2002 Feb;97(2):497-8. doi: 10.1111/j.1572-0241.2002.05512.x.
2
[Effectiveness of antiviral treatment of patients with chronic hepatitis C (a Polish multicenter study)].
Pol Merkur Lekarski. 2001 Oct;11(64):340-3.
3
4
Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation.
Transpl Int. 2004 May;17(4):169-76. doi: 10.1007/s00147-004-0695-6. Epub 2004 Apr 2.
5
[Treatment of patients with chronic hepatitis C who have not been previously treated].
Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B194-201.
6
Interferon + ribavirin combination therapy. Open new approach to treatment of patients with hepatitis C virus.
Ital J Gastroenterol Hepatol. 1999 Apr;31(3):216-7.
7
Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
Liver Int. 2006 Apr;26(3):319-25. doi: 10.1111/j.1478-3231.2005.01239.x.
8
A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
Hepatogastroenterology. 2003 Nov-Dec;50(54):2112-6.
9
High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
Hepatogastroenterology. 2003 Mar-Apr;50(50):449-52.
10
[New strategies for treatment of chronic hepatitis C].
Forum (Genova). 1999 Apr-Jun;9(2 Suppl):1-11.
Zotero 插件